The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.
Abstract
BACKGROUND: Survival after coronary artery bypass graft surgery (CABG) and medical therapy in patients with coronary artery disease (CAD) has been studied in both randomized trials and observational treatment comparisons. Over the past decade, the use of coronary angioplasty (PTCA) has increased dramatically, without guidance from either randomized trials or prospective observational comparisons. The purpose of this study was to describe the survival experience of a large prospective cohort of CAD patients treated with medicine, PTCA, or CABG. METHODS AND RESULTS: The study was designed as a prospective nonrandomized treatment comparison in the setting of an academic medical center (tertiary care). Subjects were 9263 patients with symptomatic CAD referred for cardiac catheterization (1984 through 1990). Patients with prior PTCA or CABG, valvular or congenital disease, nonischemic cardiomyopathy, or significant (> or = 75%) left main disease were excluded. Baseline clinical, laboratory, and catheterization data were collected prospectively in the Duke Cardiovascular Disease Databank. All patients were contacted at 6 months, 1 year, and annually thereafter (follow-up 97% complete). Cardiovascular death was the primary end point. Of this cohort, 2788 patients were treated with PTCA (2626 within 60 days) and 3422 with CABG (3080 within 60 days). Repeat or crossover revascularization procedures were counted as part of the initial treatment strategy. Kaplan-Meier survival curves (both unadjusted and adjusted for all known imbalances in baseline prognostic factors) were used to examine absolute survival differences, and treatment pair hazard ratios from the Cox model were used to summarize average relative survival benefits. For the latter, a 13-level CAD prognostic index was used to examine the relation between survival and revascularization as a function of CAD severity. The effects of revascularization on survival depended on the extent of CAD. For the least severe forms of CAD (ie, one-vessel disease), there were no survival advantages out to 5 years for revascularization over medical therapy. For intermediate levels of CAD (ie, two-vessel disease), revascularization was associated with higher survival rates than medical therapy. For less severe forms of two-vessel disease, PTCA had a small advantage over CABG, whereas for the most severe form of two-vessel disease (with a critical lesion of the proximal left anterior descending artery), CABG was superior. For the most severe forms of CAD (ie, three-vessel disease), CABG provided a consistent survival advantage over medicine. PTCA appeared prognostically equivalent to medicine in these patients, but the number of PTCA patients in this subgroup was low. CONCLUSIONS: In this first large-scale, prospective observational treatment comparison of PTCA, CABG, and medicine, we confirmed the previously reported survival advantages for CABG over medical therapy for three-vessel disease and severe two-vessel disease. For less severe CAD, the primary treatment choices are between medicine and PTCA. In these patients, there is a trend for a relative survival advantage with PTCA, although absolute survival differences were modest. In this setting, treatment decisions should be based not only on survival differences but also on symptom relief, quality of life outcomes, and patient preferences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082
Nonoperative Dilatation of Coronary-Artery Stenosis: Percutaneous Transluminal Coronary Angioplasty
Grüntzig, A. R., Senning, Å., & Siegenthaler, W. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907123010201 · Cited by 2,419
Results of coronary artery surgery in patients with poor left ventricular function (CASS).
Alderman, E. L., Fisher, L. D., Litwin, P., Kaiser, G. C., Myers, W. O., Maynard, C., Levine, F., & Schloss, M. (1983) · Circulation · doi:10.1161/01.cir.68.4.785 · Cited by 804
Participants, R. T. (1993) · The Lancet · doi:10.1016/0140-6736(93)90348-k · Cited by 598
Survival in medically treated coronary artery disease.
JHarris, P., EHarrell, F., LLee, K., SBehar, V., & ARosati, R. (1979) · Circulation · Cited by 252
Wiseman, A. H., Waters, D. D., Walling, A. D., Pelletier, G. B., Roy, D., & Théroux, P. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90447-0 · Cited by 53
Hartz, A. J., Kuhn, E. M., Pryor, D. B., Krakauer, H., Young, M., Heudebert, G. R., & Rimm, A. A. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91272-6 · Cited by 50
Vandormael, M. G., Deligönül, U., Taussig, S. A., & Kern, M. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90089-4 · Cited by 39
Cited by
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Diagnostic Performance of Coronary Angiography by 64-Row CT
Miller, J. M., Rochitte, C. E., Dewey, M., Arbab-Zadeh, A., Niinuma, H., Gottlieb, I., Paul, N., Clouse, M. E., Shapiro, E. P., Hoe, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806576 · Cited by 1,815
Hachamovitch, R., Hayes, S. W., Friedman, J. D., Cohen, I., & Berman, D. S. (2003) · Circulation · doi:10.1161/01.cir.0000072790.23090.41 · Cited by 1,563
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Metadata
- Authors
- Mark, D. B., Nelson, C. L., Califf, R. M., Harrell, F. E., Lee, K. L., Jones, R. H., Fortin, D. F., Stack, R. S., Glower, D. D., & Smith, L. R.
- Venue
- Circulation
- Published
- 1994-05
- Volume
- 89
- Issue
- 5
- Pages
- 2015-2025
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2133875784
- Cited by
- 421
- References
- 9
- FWCI
- 23.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.